Dominant genetic aberrations and coexistent EBV infection in HIV-related oral plasmablastic lymphomas

Loading...
Thumbnail Image

Authors

Boy, Sonja Catharina
Van Heerden, Marlene B.
Babb, Chantal
Van Heerden, Willem Francois Petrus
Pascale, Willem

Journal Title

Journal ISSN

Volume Title

Publisher

Elsevier

Abstract

We present common cytogenetic features in the largest cohort of plasmablastic lymphoma (PBL) of the oral cavity published to date. This cohort included 45 patients, 32 of whom had a known HIV status, of which 31 were HIV positive. Ninety eight per cent of all PBL cases were known to be EBV positive. In line with previous studies, we found that rearrangements of the MYC gene was the most common genetic abnormality seen in 60% of cases with the immunoglobulin heavy chain (IGH) locus as a partner in 51% of cases. Additional complex genetic aberrations were frequent, in particular, an increased copy number of the CCND1 gene was seen in 41% of cases with true amplification of CCND1 in 15% of cases. Aneuploidy was also observed for the BCL6 gene in 28% of cases. Interestingly, rearrangements of both IGH genes were detected in 16% of cases with t(14;18) and t(11;14) respectively involved in conjunction with a t(8;14) in two cases. These bi-allelic IGH rearrangements have not been described before in oral PBL. Our results reinforce the notion that EBV infection and MYC rearrangements are important events in the pathogenesis of oral PBL. The genetic diversity and complexity observed in these cases, underlines the importance to genetically characterise PBL patients at presentation as this may inform the choice of more effective treatment modalities.

Description

Keywords

Oral mucosa, HIV, MYC, CCND1, BCL6, Immunoglobulin heavy chain (IGH), Plasmablastic lymphoma (PBL), Epstein Barr virus (EBV)

Sustainable Development Goals

Citation

Sonja C. Boy, Marlene B. van Heerden, Chantal Babb, Willie F. van Heerden & Pascale Willem, Dominant genetic aberrations and coexistent EBV infection in HIV -related oral plasmablastic lymphomas, Oral Oncology, vol. 47, no. 9, pp. 883-887 (2011), doi: 10.1016/j.oraloncology.2011.06.506.